Wird geladen...
Single-agent and combination biologics in acute myeloid leukemia
Acute myeloid leukemia (AML) is a heterogeneous malignancy characterized by recurrent genetic, epigenetic, and metabolic abnormalities. As a result of our increasing knowledge of the underlying biology of AML leading to rational drug development, several new targeted agents have been recently added...
Gespeichert in:
| Veröffentlicht in: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society of Hematology
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6913489/ https://ncbi.nlm.nih.gov/pubmed/31808888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2019000059 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|